Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-11-16 19:47 | 2017-11-14 | IMMU | N/A | venBio Select Advisor LLC | Director, 10% owner, Other | Other | BUY | $10.47 | 1,325,000 | $13,868,245 | 16,064,461 | +9.0% |
| 2017-11-16 22:44 | 2017-11-16 | MRTX | N/A | venBio Select Advisor LLC | 10% owner | Other | BUY | $13.00 | 650,000 | $8,450,000 | 4,360,601 | +17.5% |
| 2017-11-16 21:45 | 2017-11-14 | LPTX | CYPHERPUNK TECHNOLOGIES INC. | HealthCare Ventures IX, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $6.09 | 1,057,769 | $6,436,524 | 3,573,376 | +42.0% |
| 2017-11-16 21:45 | 2017-11-14 | LPTX | CYPHERPUNK TECHNOLOGIES INC. | ONSI DOUGLAS E | Officer, 10% owner - CFO, GC, Treasurer & Secretary | Pharmaceutical Preparations | BUY | $6.09 | 1,057,769 | $6,436,524 | 3,573,376 | +42.0% |
| 2017-11-16 21:45 | 2017-11-14 | LPTX | CYPHERPUNK TECHNOLOGIES INC. | LAWLOR AUGUSTINE | Officer, 10% owner - Chief Operating Officer | Pharmaceutical Preparations | BUY | $6.09 | 1,057,769 | $6,436,524 | 3,573,376 | +42.0% |
| 2017-11-16 21:45 | 2017-11-14 | LPTX | CYPHERPUNK TECHNOLOGIES INC. | Mirabelli Christopher | Director, Officer, 10% owner - CEO, President, COB | Pharmaceutical Preparations | BUY | $6.09 | 1,057,769 | $6,436,524 | 3,573,376 | +42.0% |
| 2017-11-16 20:16 | 2017-11-14 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $26.25 | 50,000 | $1,312,390 | 5,698,799 | +0.9% |
| 2017-11-17 00:16 | 2017-11-14 | APO | Apollo Global Management Inc. | TIGER GLOBAL MANAGEMENT LLC | 10% owner | Investment Advice | BUY | $29.13 | 173,000 | $5,039,905 | 34,222,807 | +0.5% |
| 2017-11-17 00:22 | 2017-11-14 | SCOO | N/A | Mill Road Capital II, L.P. | 10% owner | Other | BUY | $16.55 | 518,964 | $8,588,854 | 1,487,887 | +53.6% |
| 2017-11-17 00:24 | 2017-11-14 | S | N/A | SOFTBANK GROUP CORP | 10% owner | Other | BUY | $5.98 | 2,633,814 | $15,750,208 | 3,331,360,471 | +0.1% |
| 2017-11-16 01:48 | 2017-11-14 | IMMU | N/A | Aghazadeh Behzad | Director, 10% owner, Other | Other | BUY | $10.47 | 1,325,000 | $13,868,245 | 16,064,461 | +9.0% |
| 2017-11-15 21:39 | 2017-10-16 | TERP | N/A | SUNEDISON, INC. | 10% owner | Other | BUY | $11.46 | 6,507,421 | $74,546,412 | 54,709,731 | +13.5% |
| 2017-11-16 00:32 | 2017-11-13 | APLS | Apellis Pharmaceuticals Inc. | Hillhouse Capital Management, Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 1,428,571 | $19,999,994 | 3,527,152 | +68.1% |
| 2017-11-16 02:43 | 2017-11-13 | TRN | TRINITY INDUSTRIES INC | ValueAct Holdings, L.P. | 10% owner | Railroad Equipment | BUY | $32.88 | 425,000 | $13,972,258 | 18,552,352 | +2.3% |
| 2017-11-16 00:35 | 2017-11-13 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $23.34 | 423,398 | $9,881,559 | 7,512,049 | +6.0% |
| 2017-11-16 00:33 | 2017-11-13 | MXWL | N/A | Fink Franz | Director, Officer - Chief Executive Officer | Other | BUY | $4.98 | 230,000 | $1,145,193 | 538,592 | +74.5% |
| 2017-11-16 02:43 | 2017-04-26 | T | AT&T INC. | YANG GEOFFREY Y | Director | Telephone Communications (No Radiotelephone) | BUY | $39.95 | 62,608 | $2,501,027 | 89,737 | +230.8% |
| 2017-11-16 01:12 | 2017-11-13 | GTHX | N/A | ESHELMAN FREDRIC N | Director, 10% owner | Other | BUY | $19.73 | 250,000 | $4,932,500 | 250,000 | +100.0% |
| 2017-11-16 02:30 | 2017-11-13 | COTY | COTY INC. | JAB Cosmetics B.V. | 10% owner | Perfumes, Cosmetics & Other Toilet Preparations | BUY | $16.85 | 5,400,000 | $91,015,920 | 283,208,041 | +1.9% |
| 2017-11-15 04:01 | 2017-11-10 | OMAM | N/A | HNA Capital (U.S.) Holding LLC | 10% owner | Other | BUY | $15.75 | 15,960,553 | $251,378,710 | 27,375,229 | +139.8% |
| 2017-11-15 00:31 | 2017-11-13 | APLS | Apellis Pharmaceuticals Inc. | Cormorant Asset Management, LLC | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 1,071,428 | $14,999,992 | 3,473,925 | +44.6% |
| 2017-11-15 00:25 | 2017-11-13 | XRAY | DENTSPLY SIRONA Inc. | Thierer Mark | Officer - Interim Chief Exec Officer | Dental Equipment & Supplies | BUY | $66.04 | 77,000 | $5,084,741 | 119,270 | +182.2% |
| 2017-11-14 22:08 | 2017-11-10 | MSP | N/A | Burgess Frank E | Other | Other | BUY | $12.01 | 430,000 | $5,163,010 | 485,396 | +776.2% |
| 2017-11-15 00:14 | 2017-11-10 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer - CHIEF EXECUTIVE OFFICER | Other | BUY | $5.71 | 292,991 | $1,672,539 | 151,194 | +100.0% |
| 2017-11-15 00:28 | 2017-11-13 | XRAY | DENTSPLY SIRONA Inc. | ALEXOS NICHOLAS W | Officer - EVP, CFO | Dental Equipment & Supplies | BUY | $65.85 | 50,000 | $3,292,500 | 50,000 | +100.0% |
| 2017-11-15 02:52 | 2017-11-10 | DS | N/A | EDENS WESLEY R | Director | Other | BUY | $4.09 | 561,317 | $2,298,369 | 3,622,186 | +18.3% |
| 2017-11-15 03:32 | 2017-11-10 | LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities, L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $9.64 | 575,946 | $5,554,193 | 1,369,273 | +72.6% |
| 2017-11-14 23:20 | 2017-11-10 | RHP | Ryman Hospitality Properties, Inc. | REED COLIN V | Director, Officer - Chairman & CEO | Real Estate Investment Trusts | BUY | $65.98 | 20,000 | $1,319,600 | 638,169 | +3.2% |
| 2017-11-15 02:13 | 2017-11-10 | S | N/A | SOFTBANK GROUP CORP | 10% owner | Other | BUY | $6.12 | 3,203,661 | $19,600,639 | 3,328,726,657 | +0.1% |
| 2017-11-14 01:30 | 2017-09-20 | N-A | Peakstone Realty Trust | Shields Kevin | Director, Officer - Chief Executive Officer | Real Estate Investment Trusts | BUY | $9.47 | 263,992 | $2,500,000 | 264,830 | +31,470.7% |
| 2017-11-14 00:27 | 2017-11-13 | APLS | Apellis Pharmaceuticals Inc. | venBio Global Strategic Fund II L.P. | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 127,515 | $1,785,210 | 3,579,305 | +3.7% |
| 2017-11-14 00:26 | 2017-11-13 | APLS | Apellis Pharmaceuticals Inc. | Morningside Venture Investments Ltd | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 575,000 | $8,050,000 | 11,353,303 | +5.3% |
| 2017-11-13 21:54 | 2017-11-09 | ADMA | Adma Biologics Inc. | Biotest AG | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $2.15 | 5,813,954 | $12,500,001 | 10,109,534 | +135.3% |
| 2017-11-13 21:46 | 2017-11-09 | ADMA | Adma Biologics Inc. | Grossman Adam S | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | BUY | $2.15 | 485,000 | $1,042,750 | 744,000 | +187.3% |
| 2017-11-14 01:00 | 2017-11-08 | SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | Director, Officer - President & CEO | Pharmaceutical Preparations | BUY | $52.44 | 38,138 | $1,999,957 | 420,196 | +10.0% |
| 2017-11-13 21:28 | 2017-11-08 | TREE | LendingTree, Inc. | THOMPSON G KENNEDY | Director | Loan Brokers | BUY | $264.90 | 4,000 | $1,059,600 | 9,000 | +80.0% |
| 2017-11-14 00:35 | 2017-11-08 | MKL | MARKEL GROUP INC. | Lewis Lemuel E | Director | Fire, Marine & Casualty Insurance | BUY | $1,080.96 | 1,000 | $1,080,960 | 5,294 | +23.3% |
| 2017-11-14 01:39 | 2017-11-09 | LBTY | Liberty Global Ltd. | WARGO J DAVID | Director | Cable & Other Pay Television Services | BUY | $22.08 | 75,000 | $1,655,858 | 119,445 | +168.7% |
| 2017-11-14 03:01 | 2017-11-08 | QSR | Restaurant Brands International Inc. | FRIBOURG PAUL J | Director | Retail-Eating Places | BUY | $65.10 | 384,024 | $24,999,962 | 384,024 | +100.0% |
| 2017-11-14 02:37 | 2017-11-09 | JOE | ST JOE Co | FAIRHOLME CAPITAL MANAGEMENT LLC | Director, 10% owner | Land Subdividers & Developers (No Cemeteries) | BUY | $17.98 | 154,200 | $2,773,102 | 75,000 | +100.0% |
| 2017-11-14 00:13 | 2017-11-08 | S | N/A | SOFTBANK GROUP CORP | 10% owner | Other | BUY | $6.10 | 8,645,980 | $52,740,478 | 3,325,522,996 | +0.3% |
| 2017-11-13 17:47 | 2017-11-09 | GEL | GENESIS ENERGY LP | SIMS GRANT E | Director, Officer - Chief Executive Officer | Pipe Lines (No Natural Gas) | BUY | $22.93 | 44,263 | $1,014,791 | 2,992,913 | +1.5% |
| 2017-11-10 01:39 | 2017-11-09 | HAIN | HAIN CELESTIAL GROUP INC | SIMON IRWIN D | Director, Officer - Pres., CEO & Chairman of Bd | Food and Kindred Products | BUY | $34.14 | 50,000 | $1,707,235 | 1,695,014 | +3.0% |
| 2017-11-10 00:31 | 2015-12-10 | DEST | N/A | Yeled Invest S.A. | 10% owner | Other | BUY | $9.33 | 2,243,484 | $20,932,154 | 1,921,820 | +100.0% |
| 2017-11-10 01:16 | 2017-11-07 | AMH | American Homes 4 Rent | HUGHES B WAYNE ET AL | Director | Real Estate Investment Trusts | BUY | $21.88 | 690,955 | $15,120,030 | 12,481,157 | +5.9% |
| 2017-11-10 00:14 | 2017-11-08 | MCB | Metropolitan Bank Holding Corp. | Usdan Robert I | Director | State Commercial Banks | BUY | $35.00 | 200,000 | $7,000,000 | 641,650 | +45.3% |
| 2017-11-09 23:41 | 2017-11-07 | VII | N/A | Zucker Anita G | 10% owner | Other | BUY | $0.40 | 7,500,000 | $3,000,000 | 7,885,000 | +1,948.1% |
| 2017-11-10 04:59 | 2017-11-07 | DS | N/A | EDENS WESLEY R | Director | Other | BUY | $3.97 | 398,895 | $1,584,770 | 3,341,446 | +13.6% |
| 2017-11-10 04:19 | 2017-11-07 | DXCM | DEXCOM INC | ALTMAN STEVEN R | Director | Surgical & Medical Instruments & Apparatus | BUY | $50.01 | 25,000 | $1,250,250 | 58,502 | +74.6% |
| 2017-11-09 02:02 | 2017-11-06 | FBIO | Fortress Biotech, Inc. | ROSENWALD LINDSAY A MD | Director, Officer, 10% owner - PRESIDENT, CEO | Pharmaceutical Preparations | BUY | $25.00 | 40,000 | $1,000,000 | 40,000 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.